Pediatrics: combining antimuscarinics shows promise for overactive bladder.
Jean-Jacques
JJ
Wyndaele
D001559:Benzhydryl Compounds / Q000008:administration & dosage; D002648:Child; D003408:Cresols / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D006801:Humans; D008333:Mandelic Acids / Q000008:administration & dosage; D018727:Muscarinic Antagonists / Q000008:administration & dosage*; D010372:Pediatrics / Q000379:methods; D010665:Phenylpropanolamine / Q000008:administration & dosage; D011812:Quinuclidines / Q000008:administration & dosage; D000069464:Solifenacin Succinate; D044005:Tetrahydroisoquinolines / Q000008:administration & dosage; D000068737:Tolterodine Tartrate; D053201:Urinary Bladder, Overactive / Q000188:drug therapy* / Q000473:pathology / Q000652:urine
D001559:Benzhydryl Compounds; D003408:Cresols; D008333:Mandelic Acids; D018727:Muscarinic Antagonists; D011812:Quinuclidines; D044005:Tetrahydroisoquinolines; D010665:Phenylpropanolamine; D000068737:Tolterodine Tartrate; C005419:oxybutynin; D000069464:Solifenacin Succinate